A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

January 28, 2022

Study Completion Date

January 28, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

CTP-543

CTP-543 12 mg (1 x 12 mg tablet), dosed with water

DRUG

CTP-543

CTP-543 48 mg (4 x 12 mg tablet) dosed with water

DRUG

Moxifloxacin

Moxifloxacin (1 x 400 mg tablet) dosed with water

DRUG

Placebo

Placebo (1 tablet) dosed with water

Trial Locations (1)

Clinical Pharmacology of Miami, LLC, Miami